Publications by authors named "Martin Sebastian"

Claim this Profile
P
Preoperative Immunotherapy in Oncology.
Ralf-Dieter Hofheinz, Sylvie Lorenzen, Martin Sebastian, Servet Bölükbas, Stefan Fichtner-Feigl

Dtsch Arztebl Int· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study design and rationale for the NeoTRACE trial: a multicenter phase II study of neoadjuvant sacituzumab govitecan plus zimberelimab followed by adjuvant zimberelimab with or without sacituzumab govitecan in patients with resectable non-small cell lung cancer.
Friederike C Althoff, Fabian Acker, Sebastian Koschade, Sophie Heinzen, Lukas Aguinarte, Martin Sebastian

Future Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III placebo-controlled study of eftilagimod alfa plus pembrolizumab and chemotherapy in metastatic non-small cell lung cancer.
Kenneth O'Byrne, Emilio Esteban, Cheen Leng Lee, Alinta Hegmane, Constantin Volovat, Martin Sebastian

Future Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity.
Alessio Cortellini, Edoardo Garbo, Giulia La Cava, Fabrizio Citarella, Valentina Santo, Martin Sebastian

Lung Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Tc]Tc-PSMA-HSG for PSMA-targeted Hybrid Surgical Guidance: a new addition to the PSMA-I&S/I&T family.
Margret Schottelius, David Viertl, Tessa Buckle, Hélène Koch, Sebastian Martin

Eur J Nucl Med Mol Imaging· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The untapped potential of short-read sequencing in biodiversity research.
Christoph Bleidorn, Felicia Sandberg, Sebastian Martin, Alfried P Vogler, Lars Podsiadlowski

Trends Genet· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Sequences in BRAF-V600-Mutated NSCLC: First-Line Targeted Therapy Versus First-Line (Chemo-) Immunotherapy.
Marcel Wiesweg, Ali Alaffas, Anna Rasokat, Felix Carl Saalfeld, Maximilian Rost, Martin Sebastian

J Thorac Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E-cadherin, N-cadherin and ADAM12 in localized prostate cancer: A clinicopathological study.
Natalia Pérez-Barraza, Sebastián Concha, Pedro Acuña, Sebastián San Martín, Claudio Córdova

Pathol Res Pract· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry.
Alessio Cortellini, Valentina Santo, Leonardo Brunetti, Edoardo Garbo, David J Pinato, Martin Sebastian

J Immunother Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding long-term risk in Percutaneous Coronary Intervention (PCI) in the Australian contemporary era with a focus on defining Complex Revascularisation in High-Risk Indicated Patients (CHIP).
Julian Yeoh, Garry W Hamilton, Diem Dinh, Angela Brennan, Christopher M Reid, Martin Sebastian

Cardiovasc Revasc Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOGS: A SNPSTR Marker Database to Combat Wildlife Trafficking and a Cell Culture Bank for Ex-Situ Conservation.
Annika Mozer, Camilla Bruno Di-Nizo, Albia Consul, Bruno Huettel, Richard Jäger, Sebastian Martin

Mol Ecol Resour· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of immune checkpoint inhibition combined with concurrent chemoradiotherapy in patients with stage III unresectable non-small cell lung cancer: A systematic review and meta-analysis.
Fabian Acker, Martin Reck, Daniel Martin, Stefan Rieken, Sophie Heinzen, Martin Sebastian

Eur J Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Pharmacologic Inhibition of KRAS Mutants as a Treatment for Cancer: Therapeutic Principles and Clinical Results.
Stefan Kasper, Martin Sebastian

Dtsch Arztebl Int· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased phenotypic diversity as a consequence of ecological opportunity in the island radiation of Sulawesi ricefishes (Teleostei: Adrianichthyidae).
Jan Möhring, Sebastian Hüllen, Sebastian Martin, Daniel F Mokodongan, Daisy Wowor

BMC Ecol Evol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry.
Alessio Cortellini, Leonardo Brunetti, Giuseppina Rita Di Fazio, Edoardo Garbo, David J Pinato, Martin Sebastian

J Immunother Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A chromosome-level, haplotype-resolved genome assembly and annotation for the Eurasian minnow (Leuciscidae: Phoxinus phoxinus) provide evidence of haplotype diversity.
Temitope Opeyemi Oriowo, Ioannis Chrysostomakis, Sebastian Martin, Sandra Kukowka, Thomas Brown

Gigascience· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The last of their kind: Is the genus Scutiger (Anura: Megophryidae) a relict element of the paleo-Transhimalaya biota?
Sylvia Hofmann, Lars Podsiadlowski, Tobias Andermann, Michael Matschiner, Chitra B Baniya, Sebastian Martin

Mol Phylogenet Evol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter Real-World Analysis of Combined MET and EGFR Inhibition in Patients With Non-Small Cell Lung Cancer and Acquired MET Amplification or Polysomy After EGFR Inhibition.
Fabian Acker, Alexandra Klein, Anna Rasokat, Anna Eisert, Anna Kron, Martin Sebastian, Sebastian Michels

Clin Lung Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a homotrimeric PSMA radioligand based on the NOTI chelating platform.
Sebastian Martin, Moritz-Valentin Schreck, Tobias Stemler, Stephan Maus, Florian Rosar

EJNMMI Radiopharm Chem· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can circulating tumor DNA guide treatment de-escalation in metastatic lung adenocarcinoma harboring actionable genomic alterations?
Fabian Acker, Martin Sebastian

Transl Lung Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of first-line azacitidine or decitabine with or without venetoclax in acute myeloid leukemia patients unfit for intensive therapy.
Fabian Acker, Jörg Chromik, Emily Tiedjen, Sebastian Wolf, Jonas B Vischedyk, Martin Sebastian

Eur J Haematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Analyses of Circulating Tumor DNA for the Detection of EGFR Mutation-Positive Advanced NSCLC Progression During Treatment: Data From FLAURA and AURA3.
Jhanelle E Gray, Aleksandra Markovets, Thanyanan Reungwetwattana, Margarita Majem, Naoyuki Nogami, Martin Sebastian

J Thorac Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancer.
David Planchard, Jürgen Wolf, Benjamin Solomon, Martin Sebastian, Martin Wermke

Lung Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of a Brief Safe Drinking Intervention on Depressive and Anxiety Symptomatology: Examining Potential Side Effects of Deviance Regulation Theory Interventions.
Angelina V Leary, Robert D Dvorak, Emily K Burr, Ardhys N De Leon, Samantha J Klaver, Sebastian Martin

J Drug Educ· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the C-X-C chemokine receptor 3 (CXCR3) as a target for PET imaging of T cell activation.
Sebastian Martin, Lennard Wendlinger, Béatrice Zitti, Mehdi Hicham, Viktoriia Postupalenko

EJNMMI Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis